CCM
SFE

Contrarian Capital Management’s Safeguard Scientifics, Inc. SFE Stock Holding History

Contrarian Capital Management’s Portfolio SFE Stock Details SFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,199,204
Closed -$941K – 33
2023
Q4 		$941K Hold
1,199,204
– – 0.23% 23
2023
Q3 		$1.2M Hold
1,199,204
– – 0.32% 21
2023
Q2 		$1.98M Hold
1,199,204
– – 0.53% 21
2023
Q1 		$2.06M Hold
1,199,204
– – 0.53% 20
2022
Q4 		$3.72M Hold
1,199,204
– – 0.92% 15
2022
Q3 		$4.47M Hold
1,199,204
– – 1.03% 12
2022
Q2 		$4.47M Hold
1,199,204
– – 0.82% 12
2022
Q1 		$6.26M Buy
1,199,204
+452,662
+61% +$2.74M 0.84% 11
2021
Q4 		$5.49M Buy
746,542
+45,644
+7% +$357K 0.95% 11
2021
Q3 		$6.22M Buy
700,898
+670,561
+2,210% +$5.37M 1.11% 12
2021
Q2 		$235K Buy
+30,337
New +$207K 0.03% 21

Other funds holding SFE

CP
Clayton Partners Berkeley, California $152M AUM 42.38% 1-Year Est. Return
RA
Rise Advisors Rochester, New York $355M AUM 20.51% 1-Year Est. Return
FWM
FSA Wealth Management Needham, Massachusetts $273M AUM 16.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Contrarian Capital Management's SFE Position: Q1 2024 in Review

Contrarian Capital Management sold out of Safeguard Scientifics, Inc. (SFE) in Q1 2024, closing a stake of 1,199,204 shares — an estimated $941K sold.

Contrarian Capital Management first reported a position in SFE in Q2 2021 and held it in 11 quarters. The position peaked at $6.26M in Q1 2022. 4 funds tracked by Wall St. Rank hold SFE as of Q1 2024.

  • Contrarian Capital Management reported no remaining Safeguard Scientifics, Inc. position as of Q1 2024 after selling out during the quarter.
  • Contrarian Capital Management sold 1,199,204 Safeguard Scientifics, Inc. shares in Q1 2024, an estimated $941K.
  • Contrarian Capital Management first reported a position in Safeguard Scientifics, Inc. in Q2 2021 and held it in 11 quarters.
  • Contrarian Capital Management's Safeguard Scientifics, Inc. position peaked at $6.26M in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q1 2024.

Based on Contrarian Capital Management's 13F filing for Q1 2024, filed 15 May 2024.